The global landscape of clinical trials is rapidly changing as studies become more complex. An increasing number of sponsors are seeking enhanced flexibility in their supply chains to address a variety of clinical supply challenges, including patient demand and reducing delays. Demand-led supply and direct-to-patient distribution are next-generation solutions that are helping to meet these growing needs, allowing for more streamlined processes and patient-centric studies.

Explore strategies to improve supply chain efficiency, reduce risk and respond to local, regional and global challenges

Understand how alternative supply models can be used to both improve flexibility and better align with patient needs

Explore use cases for demand-led supply and direct-to-patient supply, including potential benefits and key factors that need to be considered

Featured Speakers

Nicole Gray

Director, Strategic Supply Solutions
Catalent Pharma Solutions

Nicole Gray is currently Director, Strategic Supply Solutions for Catalent Clinical Supply Services, responsible for developing the Direct to Patient business and other new strategic service offerings. She has been in the Pharmaceutical industry for 18 years and has held multiple roles in clinical supplies project management. Prior to moving to her current role in August 2018, Nicole spent 6 years as the Director of Project Management for the Catalent Philadelphia site, responsible for a team of 45 Project Coordinators, Project Managers, and Sr. Project Managers. Prior to moving to Catalent Philadelphia, Nicole was responsible for the Mt. Laurel and Allendale Project Management teams (previously Aptuit).

Prior to joining Catalent, Nicole held various project management, communications and marketing coordination roles at Omnicare Clinical Research, GE Financial Assurance, and the United States House of Representatives. 

Nicole is an active member of the Global Clinical Supplies Group (GCSG) and is currently the Board Secretary.    

Stephen Flaherty

Global Director, Strategic Supply Solutions
Catalent Pharma Solutions

Stephen Flaherty is Global Director for Strategic Supply Solutions, in which he leads a team of Global Project Managers and Directors to define, develop and deploy several key innovative strategic supply chain solutions across the Catalent global network. These are targeted to increase efficiencies, reduce waste, improve patient access and reduce lead times for clinical supply provision and include programs such as Demand Led Services (DLS) and Direct to Patient (DTP.)

He has worked in various clinical supplies roles of increasing responsibility for 30 years, mainly focused in the Project Management area. Stephen also has (IMP) QP eligibility status.

Stephen holds an MSC in Pharmaceutical Medicine from University of Surrey and a BSc in Chemistry from University of Bradford.


Register now for this webinar